Bioverativ Enters Joint Project With UK-Based Bicycle Therapeutics
Bioverativ and a UK-based biotech company called Bicycle Therapeutics will work together to try to identify new therapies for hemophilia and also sickle cell disease. The research will focus on using a new approach – called Bicycles – which the companies hope will lead to a new way to treat the blood disorders.
Read the full press release here: Bicycle, Bioverativ Press Release.
Assisting and Advocating for the Bleeding Disorders Community